Stimulant Use and Psychosis
Lorna Saunder BSc (Hons), PG
lecture practitioner
University of Abertay, Dundee, UK
Search for more papers by this authorLorna Saunder BSc (Hons), PG
lecture practitioner
University of Abertay, Dundee, UK
Search for more papers by this authorDr Peter Phillips PhD, MSc, RMN, PGCAP, FHEA
senior lecturer honorary lecturer member specialist
City University London, UK
Search for more papers by this authorDr Olive McKeown PhD, MSc, Dip N, CELTT, Cert Obst, RMN, RGN
visiting lecturer specialist lecturer practitioner senior lecturer
St George's University, London, UK
Search for more papers by this authorTom Sandford BSc (Hons), Dip N, RGN, RMN
executive director policy adviser regional director general manager Head member
Royal College of Nursing, London, UK
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Introduction
-
Stimulant use in the United Kingdom
-
Stimulants and drug-induced psychosis
-
Stimulants and mental illness
-
Stimulants and their use by people with existing psychotic illnesses
-
Implications for practice
-
Conclusion
-
References
References
- Barber J, Luborsky L, Crits-Christoph P, et al. (1999) Therapeutic alliance as a predictor of outcome in treatment of cocaine dependence. Psychotherapy Research 9 (1): 54–73.
- Bellack A, Gearon J (1998) Substance abuse treatment for people with schizophrenia. Addictive Behaviors 23 (6): 749–766.
- Carey K (1996) Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational harm reduction approach. Community Mental Health Journal 32 (3): 291–306.
- Cassidy G, Ballard C (1994) Psychiatric sequelae of MDMA (ecstasy) and related drugs. Irish Journal of Psychological Medicine 11 (3): 132–133.
- Chivite Matthews N, Richardson A, O'Shea J, et al. (2005) Drug Misuse Declared: Findings from the British Crime Survey 2003/2004. Home Office Statistical Bulletin. Available: http://www.homeoffice.gov.uk/rds/pdfs05/hosb0405.pdf (1.11.2005).
-
Cox G, Rampes H (2003) Adverse effects of Khat: a review. Advances in Psychiatric Treatment 9: 456–463.
10.1192/apt.9.6.456 Google Scholar
- Creighton FJ, Black DL, Hyde CE (1991) “Ecstasy” psychosis and flashbacks. British Journal of Psychiatry 159: 713–715.
- Cubells J, Feinn R, Pearson D, et al. (2005) Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine Induced Psychosis (SAPS-CIP). Drug and Alcohol Dependence 80 (1): 23–33.
- Curran C, Byrappa N, McBride A (2004) Stimulant psychosis: systematic review. The British Journal of Psychiatry 185: 196–204.
- Dixon L (1999) Dual diagnosis substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 35: 93–100.
- Farren C, Hameedi F, Rosen M, et al. (2000) Significant interaction between clozapine and cocaine in cocaine addicts. Drug and Alcohol Dependence 59 (2): 153–163.
- Gearon J, Bellack A, Rachbeisel J, Dixon L (2001) Drug use behaviour and correlates in people with schizophrenia. Addictive Behaviors 26: 51–61.
- Hambrecht M, Häfner H (2003) Temporal order and aetiology. In: H Graham, A Copello, M Birchwood, K Mueser (eds). Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery, 1st Edition. Chichester: John Wiley and Sons.
- Harris D, Batki S (2000) Stimulant psychosis: symptom profile and acute clinical course. The American Journal of Addictions 9: 28–37.
- Lahti A, Weiler M, Michaelidis T, Parwani A, Tamminga C (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropyschobiopharmacology 25 (4): 455–467.
- Landabaso M, Iraurgi I, Jimenez-Lerma J, et al. (2002) Ecstasy-induced psychotic disorder: six month follow up study. European Addiction Research 8 (3): 133–140.
- Lieb R, Schuetz C, Pfister H, von Sydow K, Wittchen U (2002) Mental disorders in ecstasy users: a prospective longitudinal investigation. Drug and Alcohol Dependence 68 (2): 195–207.
- Margolese H, Malchy L, Negrete J, Tempier R, Gill K (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 67 (2–3): 157–166.
- Maxwell J (2003) Response to club drug use. Current Opinion in Psychiatry 16 (3): 279–289.
- McLaughlin D, McKenna H, Leslie J (2000) The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. Journal of Psychiatric and Mental Health Nursing 7: 435–441.
- Meier P, Barrowclough C, Donmall M (2005) The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction 100 (3): 304–316.
- Menezes P, Johnson S, Thornicroft G, et al. (1996) Drug and alcohol problems among individuals with severe mental illness in south London. British Journal of Psychiatry 168 (5): 612–619.
- Murray J (1998) Psychophysiological aspects of amphetamine and methamphetamine abuse. Journal of Psychology 132 (2): 227–237.
- Parrott AC, Sisk E, Turner J (2000) Psychobiological problems in heavy “ecstasy” (MDMA) polydrug users. Drug and Alcohol Dependence 60 (1): 105–110.
- Petry N, Bickel W (1999) Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatric Services (50): 219–227.
- Schifano F (2001) Long term effects of ecstasy consumption. Substance Misuse Bulletin 14 (1): 6–7.
- Series H, Boeles S, Dorkins E, Peveler R (1994) Psychiatric complications of “ecstasy” use. Journal of Psychopharmacology 8 (1): 60–61.
- Srisurapanont M, Kittiratanapaiboon P, Jarasuraisin N (2001) Treatment for amphetamine psychosis. The Cochrane Database of Systematic Reviews (4), Art no: CD003026. DOI: 10. 1002/14651858. CD003026.
- Strang J, Farrell M (1994) Illicit drug use: clinical features and treatment. In: J Chick, R Cantwell (eds). Seminars in Alcohol and Drug Misuse. London: Gaskell, p. 38.
- Strang J, Johns A, Caan W (1993) Cocaine in the UK 1991. British Journal of Psychiatry 162: 1–13.
- Vaiva G, Boss V, Bailly D, et al. (2001) An “accidental” acute psychosis with ecstasy use. Journal of Psychoactive Drugs 33 (1): 95–97.
- Watkins K, Hunter S, Burnham A, Pincus H, Nicholson G (2005) Review of treatment for person with co-occurring affective or anxiety and substance use disorder. Psychiatric Services 56 (8): 913–926
-
Williams A, Farrell M (2004) Substance use and psychosis. Psychiatry 3(1): 52–54.
10.1383/psyt.3.1.52.30298 Google Scholar
- Withers N, Pulvirenti L, Koob G, Gillin C (1995) Cocaine abuse and dependence. Journal of Clinical Psychopharmacology 15 (1): 63–77.
- Yui K, Goto K, Ikemoto S, et al. (2001) Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. Drug and Alcohol Dependence 64 (2): 133–142.